Literature DB >> 15875132

Anesthesia management for electroconvulsive therapy: hemodynamic and respiratory management.

Shigeru Saito1.   

Abstract

Recent guidelines have stated that anesthesia for electroconvulsive therapy (ECT) should be administered by a specially trained anesthesiologist, and that anesthesiologists have overall responsibility, not only for anesthesia itself, but also for cardiopulmonary management and emergency care. Accordingly, anesthesiologists who administer anesthesia for ECT should have sufficient knowledge regarding the physiologically and pharmacologically unique effects of ECT. Electrical current during ECT stimulates the autonomic nervous system and provokes unique hemodynamic changes in systemic and cerebral circulation. Excessive alterations in heart rate, blood pressure, and cardiac functions should be prevented by medications with anticholinergic and antihypertensive agents. Ventilation should be adequately maintained to ensure the efficacy of the therapy and to stabilize the hemodynamics immediately after the electrical stimulation. Reports of serious complications of this therapy are not frequent; however, patients with ischemic heart disease or cerebrovascular problems must be managed with special care to prevent myocardial infarction or neurological disorders. Safe physical management by anesthesiologists greatly contributes to the establishment of ECT under muscle relaxation. To maintain social confidence and to refine the therapy, anesthesiologists should play an essential role both in clinical activities and in laboratory research.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15875132     DOI: 10.1007/s00540-004-0288-7

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  10 in total

Review 1.  [Anaesthesiological aspects of electroconvulsive therapy].

Authors:  U Grundmann; M Oest
Journal:  Anaesthesist       Date:  2007-03       Impact factor: 1.041

Review 2.  [Anesthesia for electroconvulsive therapy].

Authors:  U Grundmann; S O Schneider
Journal:  Anaesthesist       Date:  2013-04       Impact factor: 1.041

3.  Effect of dexmedetomidine for attenuation of propofol injection pain in electroconvulsive therapy: a randomized controlled study.

Authors:  Xiang Li; Chao-Jin Chen; Fang Tan; Jing-Ru Pan; Ji-Bin Xing; Qian-Qian Zhu; Zi-Qing Hei; Shao-Li Zhou
Journal:  J Anesth       Date:  2017-11-10       Impact factor: 2.078

4.  Propofol protects against impairment of learning-memory and imbalance of hippocampal Glu/GABA induced by electroconvulsive shock in depressed rats.

Authors:  Jie Luo; Su Min; Ke Wei; Ping Li; Jun Dong; Yong-Feng Liu
Journal:  J Anesth       Date:  2011-07-19       Impact factor: 2.078

5.  Effects of landiolol on left ventricular function during electroconvulsive therapy: a transthoracic echocardiographic study.

Authors:  Masanobu Ide; Yuji Kadoi; Shigeru Saito; Kenichiro Takahashi; Yukari Sawano; Masumi Miyazaki; Hitoshi Shimada
Journal:  J Anesth       Date:  2010-02-06       Impact factor: 2.078

6.  General Anaesthesia Protocols for Patients Undergoing Electroconvulsive Therapy: Retrospective analysis of 504 sessions over a five-year period at a tertiary care hospital in Oman.

Authors:  Aravind Narayanan; Chandar Lal; Hamed Al-Sinawi
Journal:  Sultan Qaboos Univ Med J       Date:  2017-03-30

Review 7.  Anesthetic care for electroconvulsive therapy.

Authors:  Kyoung-Woon Joung; Dong Ho Park; Chang Young Jeong; Hong Seuk Yang
Journal:  Anesth Pain Med (Seoul)       Date:  2022-04-15

8.  Anesthetic care for electroconvulsive therapy during pregnancy -A case report-.

Authors:  Hong-Seuk Yang; Hye-Jeong Seo; Yoon Kyung Lee
Journal:  Korean J Anesthesiol       Date:  2011-03-30

9.  Medication management during electroconvulsant therapy.

Authors:  Monica Zolezzi
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-19       Impact factor: 2.570

10.  Can Propofol Lead to an Increase in Seizure Threshold Over the Course of Electroconvulsive Therapy?

Authors:  Hande Gurbuz Aytuluk; Tahsin Simsek; Mehmet Yilmaz; Ayse Zeynep Turan; Kemal Tolga Saracoglu
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-11-20       Impact factor: 2.582

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.